Published in Cancer Weekly, May 20th, 2003
According to recent research published in the journal Monatsschrift Kinderheilkunde, "Adequate treatment of childhood acute lymphoblastic leukemia (ALL) is currently able to provide a cure rate of 80%. Clinical features (e.g. age, WBC, organ involvement) and biological characteristics (translocations, immunophenotype, in vitro chemosensitivity) are used for prognostic assessment but have only limited predictive value for individual risk estimation.
"The in vivo sensitivity of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.